Legislation


LD 1 – Maine

Status: Enacted
Year Introduced: 2021
Link: http://legislature.maine.gov/legis/bills/display_ps.asp?LD=1&snum=130

This bill establishes certain requirements for the protection of health care consumers with regard to testing, treatment and immunization for COVID-19. The bill also makes changes to improve access to prescription drugs and to health care services through telehealth. Part A of the bill requires health insurance carriers to provide coverage for COVID-19 screening, testing and immunization services and prohibits a carrier from imposing any cost-sharing requirements on consumers for those services. Part B of the bill authorizes a pharmacist to administer COVID-19 vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices for administration to a person 16 years of age or older. Part B also provides that registered nurses, providers of osteopathic medicine, providers of allopathic medicine, podiatrists and dentists may prescribe to a patient a prescription drug for an extended period of time, not to exceed a 180-day supply, during a state of emergency declared by the Governor. Part C of the bill authorizes the delivery of health care services through telehealth by audio-only telephone.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found